Aerosol inhalation of human IFN-α1b exhibits anti-RSV activity in mice and favorable pharmacokinetics/safety in cynomolgus monkeys

Mingming Yang, Liping Guo, Yanran Wang, Jiangtao Bai, Xiaowen Liang, Jiahua Kuang, Hongjie Ma, Yang Yang · 2026

Read Aerosol inhalation of human IFN-α1b exhibits anti-RSV activity in mice and favorable pharmacokinetics/safety in cynomolgus monkeys by Mingming Yang, Liping Guo, Yanran Wang, Jiangtao Bai, Xiaowen Liang, Jiahua Kuang, Hongjie Ma, Yang Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171780.txt.

Description

Mingming Yang and co-authors test inhaled interferon against RSV in animals, in work from 2026. RSV is a leading cause of chest infection in infants and older adults. Treatment options once infection starts remain very limited.

In lab tests the drug blocked the virus at low doses. In infected mice, inhaled doses lowered lung virus counts step by step with dose. The drop beat a standard comparison drug under the test conditions. In monkeys, inhaling sent high drug levels to the airways while little reached the blood. Repeated daily doses were well tolerated over the study. The profile supports trials of inhaled use in people.

Catalog record

CREATORMingming Yang, Liping Guo, Yanran Wang, Jiangtao Bai, Xiaowen Liang, Jiahua Kuang, Hongjie Ma, Yang Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13171780

Browse the full library · About the Tower of Babel